CYNTHIA PARSONS: Open Payments
NPI 1164424834 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,713 in 15 payments from 13 companies in 2025. Trend: 2023 $1,138 · 2024 $1,090 · 2025 $1,713
Food & beverage: $1,713
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $254 |
| Otsuka America Pharmaceutical, Inc. | 1 | $147 |
| Amgen Inc. | 1 | $129 |
| Boston Scientific Corporation | 1 | $129 |
| Corcept Therapeutics | 1 | $127 |
| Lundbeck LLC | 1 | $126 |
| Collegium Pharmaceutical, Inc. | 1 | $125 |
| GENZYME CORPORATION | 1 | $125 |
| ABBVIE INC. | 1 | $122 |
| SANOFI-AVENTIS U.S. LLC | 1 | $120 |
Products named: INGREZZA, ABILIFY ASIMTUFII, WATCHMAN FLX, Korlym, REXULTI, Jornay PM, CEREZYME, TZIELD.
Industry payments across FL — which companies pay providers there.
